OpenEvidence, the ChatGPT for doctors, raises $200M at $6B valuation

OpenEvidence, a groundbreaking platform likened to ChatGPT for the healthcare sector, has successfully raised $200 million, leading to a remarkable valuation of $6 billion, according to The New York Times. This funding round comes just three months after the startup secured $210 million at a valuation of $3.5 billion, highlighting the burgeoning interest from investors in AI applications tailored for specific industries. The platform, which draws from extensive medical literature including journals like JAMA and the New England Journal of Medicine, enables healthcare professionals to swiftly access vital medical information to enhance patient care. Medical experts are able to utilize OpenEvidence's services at no cost, thanks to its advertising-supported model. Since its inception in 2022, OpenEvidence has expanded rapidly, with monthly clinical consultations nearly doubling to 15 million since July, as reported by the Times. The latest funding round was led by Google Ventures, with significant contributions from firms such as Sequoia Capital, Kleiner Perkins, Blackstone, Thrive Capital, Coatue Management, Bond, and Craft. TechCrunch has reached out to OpenEvidence for further insights.